BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22991935)

  • 1. Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: support for the processing speed hypothesis.
    Kelleher I; Murtagh A; Clarke MC; Murphy J; Rawdon C; Cannon M
    Cogn Neuropsychiatry; 2013; 18(1-2):9-25. PubMed ID: 22991935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.
    Kelleher I; Clarke MC; Rawdon C; Murphy J; Cannon M
    Schizophr Bull; 2013 Sep; 39(5):1018-26. PubMed ID: 22927672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
    Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Laajasalo T; Mustonen U; Kalska H; Suvisaari J; Moilanen K; Cannon TD; Huttunen M; Therman S
    Schizophr Res; 2010 Oct; 123(1):77-85. PubMed ID: 20729039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis.
    González-Ortega I; de Los Mozos V; Echeburúa E; Mezo M; Besga A; Ruiz de Azúa S; González-Pinto A; Gutierrez M; Zorrilla I; González-Pinto A
    Psychiatry Res; 2013 Mar; 206(1):8-16. PubMed ID: 22985548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.
    Brewer WJ; Francey SM; Wood SJ; Jackson HJ; Pantelis C; Phillips LJ; Yung AR; Anderson VA; McGorry PD
    Am J Psychiatry; 2005 Jan; 162(1):71-8. PubMed ID: 15625204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis.
    Ayesa-Arriola R; Pérez-Iglesias R; Rodríguez-Sánchez JM; Pardo-García G; Tabares-Seisdedos R; Ayuso-Mateos JL; Vázquez-Barquero JL; Crespo-Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():23-8. PubMed ID: 23228461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.
    Frommann I; Pukrop R; Brinkmeyer J; Bechdolf A; Ruhrmann S; Berning J; Decker P; Riedel M; Möller HJ; Wölwer W; Gaebel W; Klosterkötter J; Maier W; Wagner M
    Schizophr Bull; 2011 Jul; 37(4):861-73. PubMed ID: 20053865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can cognitive deficits facilitate differential diagnosis between at-risk mental state for psychosis and depressive disorders?
    Schulze C; Zimmermann R; Gschwandtner U; Pflueger MO; Rapp C; Studerus E; Riecher-Rössler A
    Early Interv Psychiatry; 2013 Nov; 7(4):381-90. PubMed ID: 23164358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Palau Early Psychosis Study: neurocognitive functioning in high-risk adolescents.
    Myles-Worsley M; Ord LM; Ngiralmau H; Weaver S; Blailes F; Faraone SV
    Schizophr Res; 2007 Jan; 89(1-3):299-307. PubMed ID: 17005375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis.
    Pukrop R; Ruhrmann S; Schultze-Lutter F; Bechdolf A; Brockhaus-Dumke A; Klosterkötter J
    Schizophr Res; 2007 May; 92(1-3):116-25. PubMed ID: 17344028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function.
    Gur RE; March M; Calkins ME; Weittenhiller L; Wolf DH; Turetsky BI; Gur RC
    Schizophr Res; 2015 Aug; 166(1-3):322-7. PubMed ID: 26093946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive performance and functional disability in the psychosis prodrome.
    Niendam TA; Bearden CE; Johnson JK; McKinley M; Loewy R; O'Brien M; Nuechterlein KH; Green MF; Cannon TD
    Schizophr Res; 2006 May; 84(1):100-11. PubMed ID: 16563699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faux pas recognition performance in a help-seeking population at clinical high risk of psychosis.
    Zhang T; Yi Z; Li H; Cui H; Tang Y; Lu X; Xu L; Qian Z; Zhu Y; Jiang L; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2016 Feb; 266(1):71-8. PubMed ID: 26189033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.